Search Results - "Ganne‐Carriè, Nathalie"

A novel spleen‐dedicated stiffness measurement by FibroScan® improves the screening of high‐risk oesophageal varices by Stefanescu, Horia, Marasco, Giovanni, Calès, Paul, Fraquelli, Mirella, Rosselli, Matteo, Ganne‐Carriè, Nathalie, Ledinghen, Victor, Ravaioli, Federico, Colecchia, Antonio, Rusu, Corina, Andreone, Pietro, Mazzella, Giuseppe, Festi, Davide

“…Background & Aims Several non‐invasive tests (NITs) have been developed to diagnose oesophageal varices (EV), including the recent Baveno VI criteria to rule…”
Get full text

Hepatocellular carcinoma in the setting of alcohol-related liver disease by Ganne-Carrié, Nathalie, Nahon, Pierre

“…Alcohol-related liver disease is the most prevalent type of chronic liver disease worldwide, accounting for 30% of hepatocellular carcinoma (HCC) cases and…”
Get full text

Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations by Nault, Jean-Charles, Sutter, Olivier, Nahon, Pierre, Ganne-Carrié, Nathalie, Séror, Olivier

“…Percutaneous treatment of hepatocellular carcinoma (HCC) encompasses a vast range of techniques, including monopolar radiofrequency ablation (RFA),…”
Get full text

Macrotrabecular‐massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance by Ziol, Marianne, Poté, Nicolas, Amaddeo, Giuliana, Laurent, Alexis, Nault, Jean‐Charles, Oberti, Frédéric, Costentin, Charlotte, Michalak, Sophie, Bouattour, Mohamed, Francoz, Claire, Pageaux, Georges Philippe, Ramos, Jeanne, Decaens, Thomas, Luciani, Alain, Guiu, Boris, Vilgrain, Valérie, Aubé, Christophe, Derman, Jonathan, Charpy, Cécile, Zucman‐Rossi, Jessica, Barget, Nathalie, Seror, Olivier, Ganne‐Carrié, Nathalie, Paradis, Valérie, Calderaro, Julien

“…We recently identified a histological subtype of hepatocellular carcinoma (HCC), designated as “macrotrabecular‐massive” (MTM‐HCC) and associated with specific…”
Get full text

A 17‐Beta‐Hydroxysteroid Dehydrogenase 13 Variant Protects From Hepatocellular Carcinoma Development in Alcoholic Liver Disease by Yang, Jie, Trépo, Eric, Nahon, Pierre, Cao, Qian, Moreno, Christophe, Letouzé, Eric, Imbeaud, Sandrine, Bayard, Quentin, Gustot, Thierry, Deviere, Jacques, Bioulac‐Sage, Paulette, Calderaro, Julien, Ganne‐Carrié, Nathalie, Laurent, Alexis, Blanc, Jean Frédéric, Guyot, Erwan, Sutton, Angela, Ziol, Marianne, Zucman‐Rossi, Jessica, Nault, Jean‐Charles

“…Recently, a loss of function variant (rs72613567) in 17‐beta‐hydroxysteroid dehydrogenase 13 (HSD17B13) has been identified as protective of nonalcoholic…”
Get full text

A history of variceal bleeding is associated with further bleeding under atezolizumab–bevacizumab in patients with HCC by Larrey, Edouard, Campion, Bertille, Evain, Manon, Sultanik, Philippe, Blaise, Lorraine, Giudicelli, Héloïse, Wagner, Mathilde, Cluzel, Philippe, Rudler, Marika, Ganne‐Carrié, Nathalie, Thabut, Dominique, Allaire, Manon

“…Background Atezolizumab–bevacizumab is the new standard for advanced hepatocellular carcinoma (HCC) but its impact on portal hypertension (PHT) is unknown. We…”
Get full text

Baseline ALBI score and early variation of serum AFP predicts outcomes in patients with HCC treated by atezolizumab–bevacizumab by Campani, Claudia, Bamba‐Funck, Jessica, Campion, Bertille, Sidali, Sabrina, Blaise, Lorraine, Ganne‐Carrié, Nathalie, Demory, Alix, Sutter, Olivier, Larrey, Edouard, Evain, Manon, Ghannouchi, Haroun, Wagner, Mathilde, Marra, Fabio, Sutton, Angela, Allaire, Manon, Nault, Jean‐Charles

“…Background The combination of atezolizumab and bevacizumab (AtezoBev) is the current first‐line treatment for patients with hepatocellular carcinoma (HCC). Our…”
Get full text

PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases by Yang, Jie, Trépo, Eric, Nahon, Pierre, Cao, Qian, Moreno, Christophe, Letouzé, Eric, Imbeaud, Sandrine, Gustot, Thierry, Deviere, Jacques, Debette, Stéphanie, Amouyel, Philippe, Bioulac‐Sage, Paulette, Calderaro, Julien, Ganne‐Carrié, Nathalie, Laurent, Alexis, Blanc, Jean Frédéric, Guyot, Erwan, Sutton, Angela, Ziol, Marianne, Zucman‐Rossi, Jessica, Nault, Jean‐Charles

“…Few single nucleotide polymorphisms (SNPs) have been reproducibly associated with hepatocellular carcinoma (HCC). Our aim was to test the association between…”
Get full text

Radiofrequency ablation of hepatocellular carcinoma: Long‐term results and prognostic factors in 235 Western patients with cirrhosis by N'Kontchou, Gisèle, Mahamoudi, Amel, Aout, Mounir, Ganne‐Carrié, Nathalie, Grando, Véronique, Coderc, Emmanuelle, Vicaut, Eric, Trinchet, Jean Claude, Sellier, Nicolas, Beaugrand, Michel, Seror, Olivier

“…For the treatment of small hepatocellular carcinoma (HCC), radiofrequency ablation (RFA) is in some centers considered a first‐line therapeutic option…”
Get full text

Combination of Model for End‐Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding by Walter, Aurélie, Rudler, Marika, Olivas, Pol, Moga, Lucile, Trépo, Eric, Robic, Marie Angèle, Ollivier‐Hourmand, Isabelle, Baiges, Anna, Sutter, Olivier, Bouzbib, Charlotte, Peron, Jean Marie, Le Pennec, Vincent, Ganne‐Carrié, Nathalie, Garcia‐Pagán, Juan Carlos, Mallet, Maxime, Larrue, Hélène, Dao, Thong, Thabut, Dominique, Hernández‐Gea, Virginia, Nault, Jean‐Charles, Bureau, Christophe, Allaire, Manon, Belmonte, Ernest, Betancourt, Fabian, Garcia‐Criado, Maria Angeles, Magaz, Marta, Métivier, Sophie, Musikas, Marietta, Reverter, Enric, Ripoll, Enric

“…Background and Aims Data about the prognosis of salvage transjugular intrahepatic portosystemic shunt (TIPS) using covered stents for refractory variceal…”
Get full text

Optimizing curative management of hepatocellular carcinoma by Nahon, Pierre, Vibert, Eric, Nault, Jean‐Charles, Ganne‐Carrié, Nathalie, Ziol, Marianne, Seror, Olivier

“…The goal of curative management of hepatocellular carcinoma is to provide the best chance of remission. However, recurrence rates for both local and distant…”
Get full text

No correlation between MASLD and poor outcome of Atezolizumab-Bevacizumab therapy in patients with advanced HCC by Copil, Francisca-Dora, Campani, Claudia, Lequoy, Marie, Sultanik, Philippe, Blaise, Lorraine, Wagner, Mathilde, Ganne-Carrié, Nathalie, Ozenne, Violaine, Thabut, Dominique, Nault, Jean-Charles, Ratziu, Vlad, Allaire, Manon

“…It has been suggested that in patients with hepatocellular carcinoma (HCC) of metabolic aetiology, the efficacy of immunotherapy may be reduced. The aim was to…”
Get full text

Upfront multi‐bipolar radiofrequency ablation for HCC in transplant‐eligible cirrhotic patients with salvage transplantation in case of recurrence by Boros, Carina, Sutter, Olivier, Cauchy, François, Ganne‐Carrié, Nathalie, Nahon, Pierre, N'kontchou, Gisele, Ziol, Marianne, Grando, Véronique, Demory, Alix, Blaise, Lorraine, Dondero, Fédérica, Durand, François, Soubrane, Olivier, Lesurtel, Mickael, Laurent, Alexis, Seror, Oliver, Nault, Jean Charles

“…Introduction We aim to assess the long‐term outcomes of percutaneous multi‐bipolar radiofrequency (mbpRFA) as the first treatment for hepatocellular carcinoma…”
Get full text

Liver Stiffness by Transient Elastography to Detect Porto‐Sinusoidal Vascular Liver Disease With Portal Hypertension by Elkrief, Laure, Lazareth, Marie, Chevret, Sylvie, Paradis, Valérie, Magaz, Marta, Blaise, Lorraine, Rubbia‐Brandt, Laura, Moga, Lucile, Durand, François, Payancé, Audrey, Plessier, Aurélie, Chaffaut, Cendrine, Valla, Dominique, Malphettes, Marion, Diaz, Alba, Nault, Jean‐Charles, Nahon, Pierre, Audureau, Etienne, Ratziu, Vlad, Castera, Laurent, Garcia Pagan, Juan‐Carlos, Ganne‐Carrie, Nathalie, Rautou, Pierre‐Emmanuel

“…Background and Aims Porto‐sinusoidal vascular liver disease (PSVD) is a rare cause of portal hypertension. PSVD is still often misdiagnosed as cirrhosis,…”
Get full text

Long‐term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma by Alitti, Clémentine, Rode, Agnès, Trillaud, Hervé, Merle, Philippe, Blanc, Jean‐Frédéric, Blaise, Lorraine, Demory, Alix, Nkontchou, Gisele, Grando, Véronique, Ziol, Marianne, Nahon, Pierre, Ganne‐Carrié, Nathalie, Petit, Arthur, Seror, Olivier, Sutter, Olivier, Nault, Jean‐Charles

“…Introduction The effectiveness of percutaneous radiofrequency ablation (RFA) in intrahepatic cholangiocarcinomas (iCCA) remains insufficiently studied. Methods…”
Get full text

Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases by Ganne‐Carrié, Nathalie, Ziol, Marianne, de Ledinghen, Victor, Douvin, Catherine, Marcellin, Patrick, Castera, Laurent, Dhumeaux, Daniel, Trinchet, Jean‐Claude, Beaugrand, Michel

“…A proper diagnosis of cirrhosis is essential for the management of patients with chronic liver diseases. We assessed the accuracy of liver stiffness…”
Get full text

Percutaneous radiofrequency ablation for hepatocellular carcinoma developed on non‐alcoholic fatty liver disease by Nguyen, Nga, Rode, Agnès, Trillaud, Hervé, Aubé, Christophe, Manichon, Anne Frédérique, Hocquelet, Arnaud, Paisant, Anita, Dao, Thong, Nahon, Pierre, Ganne‐Carrié, Nathalie, Blaise, Lorraine, Cauchy, François, Sutter, Olivier, Séror, Olivier, Nault, Jean‐Charles

“…Background & Aims Long‐term outcomes after percutaneous radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) in patients with non‐alcoholic fatty…”
Get full text

Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments by Campani, Claudia, Imbeaud, Sandrine, Couchy, Gabrielle, Ziol, Marianne, Hirsch, Theo Z, Rebouissou, Sandra, Noblet, Bénédicte, Nahon, Pierre, Hormigos, Katia, Sidali, Sabrina, Seror, Olivier, Taly, Valerie, Ganne Carrie, Nathalie, Laurent-Puig, Pierre, Zucman-Rossi, Jessica, Nault, Jean-Charles

“…Circulating tumour DNA (ctDNA) is a promising non-invasive biomarker in cancer. We aim to assess the dynamic of ctDNA in patients with hepatocellular carcinoma…”
Get more information

ESM1 as a Marker of Macrotrabecular-Massive Hepatocellular Carcinoma by Calderaro, Julien, Meunier, Léa, Nguyen, Cong Trung, Boubaya, Marouane, Caruso, Stefano, Luciani, Alain, Amaddeo, Giuliana, Regnault, Hélène, Nault, Jean-Charles, Cohen, Justine, Oberti, Frédéric, Michalak, Sophie, Bouattour, Mohamed, Vilgrain, Valérie, Pageaux, Georges Philippe, Ramos, Jeanne, Barget, Nathalie, Guiu, Boris, Paradis, Valérie, Aubé, Christophe, Laurent, Alexis, Pawlotsky, Jean-Michel, Ganne-Carrié, Nathalie, Zucman-Rossi, Jessica, Seror, Olivier, Ziol, Marianne

“…Macrotrabecular-massive hepatocellular carcinoma (MTM-HCC) is a novel morphological subtype of HCC associated with early relapse after resection or…”
Get full text

Body weight changes and duration of estrogen exposure modulate the evolution of hepatocellular adenomas after contraception discontinuation by Demory, Alix, Péron, Jean-Marie, Calderaro, Julien, Selves, Janick, Mokrane, Fatima-Zohra, Amaddeo, Giuliana, Paradis, Valérie, Ziol, Marianne, Sutter, Olivier, Blaise, Lorraine, Ganne-Carrié, Nathalie, Vilgrain, Valérie, Cauchy, François, Zucman-Rossi, Jessica, Ronot, Maxime, Nault, Jean-Charles

“…The natural history of hepatocellular adenomas (HCAs) remains to be better described, especially in nonresected patients. We aim to identify the predictive…”
Get full text